The companies who participate in the pharmaceutical supply chain need a pedigree approach that will allow them to comply with multiple state and federal pedigree laws that have different requirements. Due to the nature of the modern US drug supply chain, it is impossible to predict where a drug entering the supply chain will ultimately exit the chain and which pedigree laws it must comply with along the way. Companies that participate in the pharmaceutical supply chain also want to be able to selectively share serial number visibility data about the serialized products that pass through the supply chain.
Business Process Documentation :
Functional and Technical Design :
Tools :
Continuous Support :